Development and clinical evaluation of fluorescent tattoo system for radiation therapy
- 1Department of Radiation Oncology, Seoul National University Hospital
Abstract
Conventional dark-ink tattoos used for radiotherapy positioning may remain permanently visible. We developed a fluorescent tattoo system comprising a medical tattoo device, fluorescent ink, and ultraviolet (UV) lamps and evaluated its clinical feasibility. Twenty-four patients prospectively received fluorescent tattoos, and setup displacement and procedure times were compared with those of 24 retrospectively selected patients with conventional dark-ink tattoos. The time required for tattooing and patient treatment setup was estimated. The setup errors were determined using CBCT. Pain, satisfaction, and adverse events were evaluated prospectively in the fluorescent group. Lamps with wavelengths in the UVA range were developed. The appropriate needle vibration frequency and needle type for tattoo procedures were determined. CBCT-based setup displacement did not differ significantly between groups. Median CT simulation time was longer with fluorescent tattoos, whereas treatment setup time was similar. The VAS score was evaluated as 1.9 ± 0.8. The patients were highly satisfied with the availability of showers and the invisible marker. No tattoo-related adverse events were reported during a three-year medical-record review. In this small, non-randomized cohort, the fluorescent tattoo system was clinically feasible and showed no significant difference in CBCT-based setup displacement from conventional dark-ink tattoos. It may offer a cosmetically inconspicuous option for selected patients, although UV illumination, longer application time, limited cohort diversity, and long-term pigment safety require further study.
Related
- Advances in Stereotactic Body Radiation Therapy: Expanding Clinical Applications and Improving Treatment Precision
- Surface-guided Radiation Therapy in Clinical Practice: A Review with Perspectives on Implementation in Resource-constrained Settings
- Radiation therapy in breast cancer patients in south west Nigeria: an evaluation of protocols in a specialist cancer centre
- AAPM Medical Physics Practice Guideline 18.a: Superficial radiation therapy using low-energy kilovoltage x-rays.
- Dosimetric Outcomes of Definitive Radiation Therapy to Anal Squamous Cell Carcinoma in a Single Institution Using Volumetric Modulated Arc Therapy Evaluated Against Australian and International Treatment Planning Guidelines
BibTeX
@article{choi2026development,
title = {{Development and clinical evaluation of fluorescent tattoo system for radiation therapy}},
author = {Chang Heon Choi and Hong-Gyun Wu and Hak Jae Kim and Jin Ho Kim and Hyun-Cheol Kang and Kyung Su Kim and Seonghee Kang and Jin Jegal and Jung-in Kim},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-62916-2},
url = {https://doi.org/10.1038/s41598-026-62916-2},
note = {CC BY},
}
RIS
TY - JOUR
TI - Development and clinical evaluation of fluorescent tattoo system for radiation therapy
AU - Chang Heon Choi
AU - Hong-Gyun Wu
AU - Hak Jae Kim
AU - Jin Ho Kim
AU - Hyun-Cheol Kang
AU - Kyung Su Kim
AU - Seonghee Kang
AU - Jin Jegal
AU - Jung-in Kim
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-62916-2
UR - https://doi.org/10.1038/s41598-026-62916-2
AB - Conventional dark-ink tattoos used for radiotherapy positioning may remain permanently visible. We developed a fluorescent tattoo system comprising a medical tattoo device, fluorescent ink, and ultraviolet (UV) lamps and evaluated its clinical feasibility. Twenty-four patients prospectively received fluorescent tattoos, and setup displacement and procedure times were compared with those of 24 retrospectively selected patients with conventional dark-ink tattoos. The time required for tattooing and patient treatment setup was estimated. The setup errors were determined using CBCT. Pain, satisfaction, and adverse events were evaluated prospectively in the fluorescent group. Lamps with wavelengths in the UVA range were developed. The appropriate needle vibration frequency and needle type for tattoo procedures were determined. CBCT-based setup displacement did not differ significantly between groups. Median CT simulation time was longer with fluorescent tattoos, whereas treatment setup time was similar. The VAS score was evaluated as 1.9 ± 0.8. The patients were highly satisfied with the availability of showers and the invisible marker. No tattoo-related adverse events were reported during a three-year medical-record review. In this small, non-randomized cohort, the fluorescent tattoo system was clinically feasible and showed no significant difference in CBCT-based setup displacement from conventional dark-ink tattoos. It may offer a cosmetically inconspicuous option for selected patients, although UV illumination, longer application time, limited cohort diversity, and long-term pigment safety require further study.
SN - 2045-2322
ER -